tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RARE Stock Latest News

Ultragenyx price target raised to $83 from $73 at BofA
The FlyUltragenyx price target raised to $83 from $73 at BofA
3m ago
RARE
Inozyme appoints Erik Harris to board of directors
PremiumThe Fly
Inozyme appoints Erik Harris to board of directors
7d ago
INZY
RARE
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
PremiumThe Fly
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
7d ago
RARE
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
PremiumThe Fly
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
9d ago
RARE
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
PremiumThe Fly
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
9d ago
PEV
IRIX
Passage Bio appoints Tom Kassberg to board of directors
PremiumThe FlyPassage Bio appoints Tom Kassberg to board of directors
1M ago
PASG
RARE
Truist biotech analysts hold an analyst/industry conference call
Premium
The Fly
Truist biotech analysts hold an analyst/industry conference call
2M ago
IONS
RARE
Abeona Therapeutics appoints Zeiher, Crombez to board of directors
Premium
The Fly
Abeona Therapeutics appoints Zeiher, Crombez to board of directors
2M ago
ABEO
RARE
Ultragenyx price target lowered to $81 from $83 at Barclays
PremiumThe Fly
Ultragenyx price target lowered to $81 from $83 at Barclays
2M ago
RARE
Top Stock Gainers Today – TNDM, TWLO, and More
PremiumMarket News
Top Stock Gainers Today – TNDM, TWLO, and More
2M ago
RKT
RARE
3 Best Stocks to Buy Now, 8/2/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 8/2/2024, According to Top Analysts 
2M ago
ATEC
IBKR
Ultragenyx raises FY24 revenue view to $530M-$550M from $500M-$530M
PremiumThe Fly
Ultragenyx raises FY24 revenue view to $530M-$550M from $500M-$530M
2M ago
RARE
Ultragenyx reports Q2 EPS ($1.52), consensus ($1.69)
PremiumThe FlyUltragenyx reports Q2 EPS ($1.52), consensus ($1.69)
2M ago
RARE
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
RARE
Ultragenyx to present GTX-102 Angelman syndrome program update
Premium
The Fly
Ultragenyx to present GTX-102 Angelman syndrome program update
3M ago
RARE
Ultragenyx announces end-of-Phase 2 meeting with FDA for GTX-102
PremiumThe Fly
Ultragenyx announces end-of-Phase 2 meeting with FDA for GTX-102
3M ago
RARE
Ultragenyx Shareholders Approve Directors and Incentive Plans
PremiumCompany Announcements
Ultragenyx Shareholders Approve Directors and Incentive Plans
4M ago
8K
RARE
Mereo BioPharma price target raised to $8 from $6 at Leerink
PremiumThe Fly
Mereo BioPharma price target raised to $8 from $6 at Leerink
4M ago
MREO
RARE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
RNA
AXSM
Ultragenyx 7.44M share Secondary priced at $39.00
PremiumThe FlyUltragenyx 7.44M share Secondary priced at $39.00
4M ago
RARE
Ultragenyx announces $350M common stock, warrants offering
Premium
The Fly
Ultragenyx announces $350M common stock, warrants offering
4M ago
RARE
Ultragenyx plans to file for accelerated approval of UX111
Premium
The Fly
Ultragenyx plans to file for accelerated approval of UX111
4M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >